cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Rubius Therapeutics Inc
25 own
26 watching
Current Price
$0.28
$-0.02
(-5.27%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
25.16M
52-Week High
52-Week High
6.54
52-Week Low
52-Week Low
0.14
Average Volume
Average Volume
0.56M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
129.7053
iconMarket Capitalization25.16M
icon52-Week High6.54
icon52-Week Low0.14
iconAverage Volume0.56M
iconDividend Yield--
iconP/E Ratio129.7053
What does the Rubius Therapeutics Inc do?
N/A
Read More
How much money does Rubius Therapeutics Inc make?
News & Events about Rubius Therapeutics Inc.
PR Newswire
3 months ago
Alltrna Appoints Caroline Khrer, Ph.D., Vice President, Discovery Platform Alltrna Appoints Caroline Khrer, Ph.D., Vice President, Discovery Platform PR Newswire CAMBRIDGE, Mass., Oct. 17, 2022 Dr. Khrer has more than 25 years of RNA research and development experience, including pioneering novel...
PR Newswire
4 months ago
Thinking about buying stock in Rubius Therapeutics, NextPlat, Seres Therapeutics, Cassava Sciences, or Alaunos Therapeutics? Thinking about buying stock in Rubius Therapeutics, NextPlat, Seres Therapeutics, Cassava Sciences, or Alaunos Therapeutics? PR Newswire NEW YORK, Sept. 23, 2022 NEW YORK...
Globe Newswire
4 months ago
CAMBRIDGE, Mass., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a biopharmaceutical company that is developing an entirely new class of cellular medicines called Red Cell Therapeutics for the treatment of cancer and autoimmune diseases, today announced that Pablo J. ...
PR Newswire
4 months ago
Thinking about buying stock in Mullen Automotive, American Virtual Cloud Technologies, IVERIC Bio, Rubius Therapeutics, or Globalstar? Thinking about buying stock in Mullen Automotive, American Virtual Cloud Technologies, IVERIC Bio, Rubius Therapeutics, or Globalstar? PR Newswire NEW YORK, Sept...
Benzinga
5 months ago
Rubius Therapeutics's (NASDAQ:RUBY) short percent of float has risen 27.45% since its last report. The company recently reported that it has 3.52 million shares sold short, which is 10.54% of all regular shares that are available for trading. read more...
Frequently Asked Questions
Frequently Asked Questions
What is Rubius Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Rubius Therapeutics Inc shares?
plus_minus_icon
How can I buy Rubius Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Rubius Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Rubius Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Rubius Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Rubius Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Rubius Therapeutics Inc?
plus_minus_icon
What percentage is Rubius Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Rubius Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0.28
$-0.02
(-5.27%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00